Contributor: Sharpening All the Tools in the Value Assessment Toolbox
A German-style fair value/pricing committee may be in the works for the United States. However, government payers still have work to do before implementing a value assessment system.
Why Accounting for Our Differences Matter in Assessing Drug Value
The authors discuss how more efforts need to ensure the methods used to measure the “value” of new therapies include factors that reflect patient heterogeneity.
